What kind of doctor treats lupus? It's a common question for those who may have or have been diagnosed with systemic lupus erythematosus (SLE) or another form of lupus. Since most people with lupus ...

Systemic Lupus Erythematosus (SLE): Around 70% of people with lupus have this type. It causes acute and chronic inflammation to a number of organs and organ systems. Cutaneous Lupus (lupus skin ...

The patient is a 45-year-old Caucasian male with a 5-year history of systemic lupus erythematosus (SLE). He has flat erythema that is more prominent on the upper chest, neck, and head. The rash ...

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can cause diverse ... Patient data were collected retrospectively, and included general information (gender, age, ...

Objectives To analyse the new evidence (2018–2022) for the management of systemic lupus erythematosus (SLE) to inform the 2023 update of the European League Against Rheumatism (EULAR) recommendations.

Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread inflammation and tissue damage that can affect any part of the body. Commonly affected ...

Objectives: Treatment of Systemic Lupus Erythematosus (SLE) is characterized by a largely empirical approach and relative paucity of novel compound development. We sought to stratify SLE patients ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Objective Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disorder with no reliable serum biomarkers currently available other than autoantibodies. Methods In the present study, ...

Objective: To investigate differences in clinical signs and symptoms, and in antinuclear antibodies (ANA), between patients with juvenile-onset and adult-onset systemic lupus erythematosus (SLE).

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...